论文部分内容阅读
卵巢癌易于转移及复发。一些研究报道显示对已达到临床痊愈的患者,停止治疗后,约50%~80%的患者会在近期或远期出现复发〔1〕,再次治疗达到完全缓解的可能性很小。目前的治疗很大程度上是一种以个体化为原则的姑息性治疗,着重于减轻癌症引起的相关症状,改善患者生存质量,延长疾
Ovarian cancer is prone to metastasis and recurrence. Some studies have shown that patients who have achieved clinical recovery, stop treatment, about 50% to 80% of patients will relapse in the short term or long-term [1], re-treatment is unlikely to achieve complete remission. The current treatment is largely a palliative treatment based on the principle of individualism, focusing on alleviating the symptoms associated with cancer, improving patient quality of life, prolonging the condition